The stock of Innophos Holdings, Inc. (NASDAQ:IPHS) is a huge mover today! The stock increased 10.09% or $4.17 during the last trading session, hitting $45.5. About 500,651 shares traded hands or 328.75% up from the average. Innophos Holdings, Inc. (NASDAQ:IPHS) has risen 41.59% since March 28, 2016 and is uptrending. It has outperformed by 36.88% the S&P500.
The move comes after 8 months positive chart setup for the $885.15M company. It was reported on Oct, 28 by Barchart.com. We have $57.33 PT which if reached, will make NASDAQ:IPHS worth $230.14 million more.
Analysts await Innophos Holdings, Inc. (NASDAQ:IPHS) to report earnings on November, 1. They expect $0.66 EPS, 0.00% or $0.00 from last year’s $0.66 per share. IPHS’s profit will be $12.84 million for 17.23 P/E if the $0.66 EPS becomes a reality. After $0.61 actual EPS reported by Innophos Holdings, Inc. for the previous quarter, Wall Street now forecasts 8.20% EPS growth.
Innophos Holdings, Inc. (NASDAQ:IPHS) Ratings Coverage
Out of 2 analysts covering Innophos Holdings (NASDAQ:IPHS), 1 rate it a “Buy”, 1 “Sell”, while 0 “Hold”. This means 50% are positive. Innophos Holdings has been the topic of 3 analyst reports since August 24, 2015 according to StockzIntelligence Inc. The stock of Innophos Holdings, Inc. (NASDAQ:IPHS) earned “Sell” rating by Zacks on Monday, August 24. The stock has “Buy” rating given by Sidoti on Thursday, October 20. The firm earned “Sell” rating on Thursday, September 3 by Zacks.
According to Zacks Investment Research, “Innophos, Inc., is one of the leading North American manufacturers of specialty phosphates, serving a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications. Innophos’ market-leading positions derive from its experience and dedication to customer service and innovation.”
Insitutional Activity: The institutional sentiment decreased to 1.22 in Q2 2016. Its down 0.15, from 1.37 in 2016Q1. The ratio worsened, as 14 funds sold all Innophos Holdings, Inc. shares owned while 53 reduced positions. 30 funds bought stakes while 52 increased positions. They now own 17.50 million shares or 0.21% more from 17.46 million shares in 2016Q1.
Mufg Americas Holdg holds 0% of its portfolio in Innophos Holdings, Inc. (NASDAQ:IPHS) for 342 shares. Moreover, Sit Assocs has 0% invested in Innophos Holdings, Inc. (NASDAQ:IPHS) for 1,325 shares. Paloma Partners Com holds 0.01% of its portfolio in Innophos Holdings, Inc. (NASDAQ:IPHS) for 15,311 shares. Alpha Windward Lc last reported 10,920 shares in the company. Boston Prtn owns 152,817 shares or 0.01% of their US portfolio. Barclays Public Limited Com accumulated 28 shares or 0% of the stock. Blackrock Fund Advisors has 0.01% invested in the company for 1.26M shares. Heartland holds 0.4% or 170,245 shares in its portfolio. Geode Mngmt Ltd Llc last reported 0% of its portfolio in the stock. Motley Fool Asset Mgmt Limited Liability Co reported 172,601 shares or 1.59% of all its holdings. Kestrel Inv Corp, a California-based fund reported 135,000 shares. Legal And General Gru Public Limited Liability Com accumulated 0% or 4,415 shares. Aperio Gp Ltd Limited Liability Company holds 6,315 shares or 0% of its portfolio. Schwab Charles Invest Management has 131,427 shares for 0.01% of their US portfolio. The North Carolina-based Commercial Bank Of America De has invested 0% in Innophos Holdings, Inc. (NASDAQ:IPHS).
Insider Transactions: Since May 20, 2016, the stock had 2 insider purchases, and 0 selling transactions for $77,419 net activity. $40,310 worth of Innophos Holdings, Inc. (NASDAQ:IPHS) was bought by Zatta Robert J.
More notable recent Innophos Holdings, Inc. (NASDAQ:IPHS) news were published by: Prnewswire.com which released: “Innophos Holdings, Inc. Reports Third Quarter 2016 Results” on October 27, 2016, also Prnewswire.com with their article: “Innophos Holdings, Inc. Appoints Joshua Horenstein As Chief Legal Officer And …” published on September 09, 2016, Prnewswire.com published: “Innophos Holdings, Inc. Reports Third Quarter 2015 Results” on November 03, 2015. More interesting news about Innophos Holdings, Inc. (NASDAQ:IPHS) were released by: Prnewswire.com and their article: “Innophos Holdings, Inc. Appoints Han Kieftenbeld As Chief Financial Officer” published on April 04, 2016 as well as Prnewswire.com‘s news article titled: “Innophos To Host Third-quarter 2016 Financial Results Conference Call On …” with publication date: October 13, 2016.
IPHS Company Profile
Innophos Holdings, Inc., incorporated July 15, 2004, is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Firm also provides bioactive mineral and nutritional ingredients. The Company’s divisions include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and GTSP & Other. The Specialty Phosphates US & Canada segment and Specialty Phosphates Mexico segment comprises product lines, such as Specialty Ingredients; Food and Technical Grade Purified Phosphoric Acid (PPA), and Technical Grade Sodium Tripolyphosphate (STPP) & Detergent Grade PPA. The GTSP & Other segment includes fertilizer co-product Granular Triple Super Phosphate (GTSP) and other non-specialty phosphate products. The Specialty Phosphates US & Canada segment and the Specialty Ingredients product line includes the activities of Innophos Nutrition, Inc.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.